Matches in Wikidata for { <http://www.wikidata.org/entity/Q91483917> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q91483917 description "article scientifique publié en 2019" @default.
- Q91483917 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91483917 description "scientific article published on 27 November 2019" @default.
- Q91483917 description "wetenschappelijk artikel" @default.
- Q91483917 description "наукова стаття, опублікована 27 листопада 2019" @default.
- Q91483917 name "Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India" @default.
- Q91483917 name "Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India" @default.
- Q91483917 type Item @default.
- Q91483917 label "Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India" @default.
- Q91483917 label "Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India" @default.
- Q91483917 prefLabel "Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India" @default.
- Q91483917 prefLabel "Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India" @default.
- Q91483917 P1433 Q91483917-35CC993D-1310-45CD-9C40-E0BF9A93810A @default.
- Q91483917 P1476 Q91483917-7FA3FA02-A5CA-4C4E-AF85-3A44F7116719 @default.
- Q91483917 P2093 Q91483917-0F277F72-155C-4709-94CE-8704B8ACECCF @default.
- Q91483917 P2093 Q91483917-378495FB-193A-42A1-981A-D2DA1BCE07EE @default.
- Q91483917 P2093 Q91483917-88C5E355-8C34-458A-AB2F-762FA38940A0 @default.
- Q91483917 P2093 Q91483917-A4C09658-BE91-4B64-BC4B-9041A43616EF @default.
- Q91483917 P2093 Q91483917-A739BD0D-9CBF-46D4-A96F-454BEF4FD887 @default.
- Q91483917 P2093 Q91483917-D4BEF8A4-9B92-4C0E-A8DD-158D926CFE9C @default.
- Q91483917 P2093 Q91483917-E9FE25DE-C216-44E9-8B4E-EDA0288C7518 @default.
- Q91483917 P2093 Q91483917-EF9932D0-E045-4D30-B59A-0B2157347D5F @default.
- Q91483917 P2093 Q91483917-F280CACD-F7E3-4EAE-8F96-252C1D6B51BB @default.
- Q91483917 P304 Q91483917-EA2AC8F1-6736-493D-B336-7B45D3424938 @default.
- Q91483917 P31 Q91483917-957AC6CA-789F-4DC9-8C7E-C77B0C1E3990 @default.
- Q91483917 P356 Q91483917-58E2EB21-FECC-48F0-85B3-3C73174C7325 @default.
- Q91483917 P433 Q91483917-D1938939-D483-46CD-9D6C-63DE59957C9C @default.
- Q91483917 P478 Q91483917-83B9A307-E9CC-4D1B-BE54-82CE2651EFE5 @default.
- Q91483917 P50 Q91483917-ED2CCAC1-ABCC-491B-9BFE-AA30B8F8531C @default.
- Q91483917 P50 Q91483917-F40C227E-517C-4F7D-AAA3-D4B94A89060D @default.
- Q91483917 P577 Q91483917-3B8D1B9E-C970-4B05-8655-ADBA87D68CC6 @default.
- Q91483917 P698 Q91483917-599BE79F-C86F-4700-B43D-279A1E898986 @default.
- Q91483917 P921 Q91483917-E4E66605-72CB-4611-9041-806950746E2F @default.
- Q91483917 P356 10428194.2019.1695054 @default.
- Q91483917 P698 31774004 @default.
- Q91483917 P1433 Q6534493 @default.
- Q91483917 P1476 "Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India" @default.
- Q91483917 P2093 "Deepa Phillip" @default.
- Q91483917 P2093 "Epari Sridhar" @default.
- Q91483917 P2093 "Maya Prasad" @default.
- Q91483917 P2093 "Nirmalya D Pradhan" @default.
- Q91483917 P2093 "Seema Kembhavi" @default.
- Q91483917 P2093 "Shripad D Banavali" @default.
- Q91483917 P2093 "Sneha Shah" @default.
- Q91483917 P2093 "Sumeet Gujral" @default.
- Q91483917 P2093 "Tanuja Shet" @default.
- Q91483917 P304 "912-918" @default.
- Q91483917 P31 Q13442814 @default.
- Q91483917 P356 "10.1080/10428194.2019.1695054" @default.
- Q91483917 P433 "4" @default.
- Q91483917 P478 "61" @default.
- Q91483917 P50 Q57056348 @default.
- Q91483917 P50 Q91049693 @default.
- Q91483917 P577 "2019-11-27T00:00:00Z" @default.
- Q91483917 P698 "31774004" @default.
- Q91483917 P921 Q422232 @default.